Anticorps Recombinant de lapin anti-SLAMF7/CD319

SLAMF7/CD319 Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC

Conjugaison

Non conjugué

CloneNo.

241321F11

N° de cat : 98093-1-RR

Synonymes

SLAMF7, 241321F11, CD2-like receptor-activating cytotoxic cells, CD319, CRACC

---

Galerie de données de validation

• 

  FC experiment of human PBMCs using 98093-1-RR

  1x10^6 human PBMCs were surface stained with 0.25 ug Anti-Human SLAMF7/CD319 Rabbit RecAb (98093-1-RR, Clone:241321F11) or 0.25 ug Rabbit IgG Isotype Control RecAb (98136-1-RR, Clone: 240953C9), and PE-Conjugated Goat Anti-Rabbit IgG(H+L). Cells were then stained with CoraLite® Plus 647 Anti-Human CD3 (OKT3) Mouse IgG2a Recombinant Antibody (CL647-65569, Clone: OKT3). Cells were not fixed. Lymphocytes were gated.

• 

  FC experiment of human PBMCs using 98093-1-RR

  1x10^6 human PBMCs were surface stained with 0.25 ug Anti-Human SLAMF7/CD319 Rabbit RecAb (98093-1-RR, Clone: 241321F11) (red) or 0.25 ug Rabbit IgG Isotype Control RecAb (98136-1-RR, Clone: 240953C9) (blue), and PE-Conjugated Goat Anti-Rabbit IgG(H+L). Cells were not fixed. Lymphocytes were gated.

• 

  Affinity and Kinetic Characterization of 98093-1-RR

  Biolayer interferometry (BLl) kinetic assays of 98093-1-RR against Human SLAMF7/CD319 were performed. The affinity constant is 0.634 nM.

---

Applications testées

• Résultats positifs en cytométrie: CMSP humaines,

Dilution recommandée

Application	Dilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98093-1-RR cible SLAMF7/CD319 dans les applications de FC et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: Protéine recombinante
• Nom complet: SLAM family member 7
• Masse moléculaire calculée: 335 aa, 37 kDa
• Numéro d’acquisition GenBank: BC027867
• Symbole du gène: SLAMF7
• Identification du gène (NCBI): 57823
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Protein A purfication
• Tampon de stockage: PBS with 0.09% sodium azide
• Conditions de stockage: Store at 2 - 8°C. Stable for one year after shipment.

Informations générales

Signaling lymphocyte activation molecule (SLAM) family receptors is a group of type I transmembrane receptors belonging to the immunoglobulin superfamily (PMID: 37251372). The SLAM family contains nine members that contain an extracellular segment comprising two or four Ig-like domains (V-like variable and C2-like constant), a transmembrane region and a cytoplasmic tail (PMID: 29662641). They are involved in various physiological and pathological processes, including the regulation of immunological responses and the route of viral entry. SLAMF7, also known as CS1, CRACC or CD319, is expressed on NK cells, CD8+ T lymphocytes, B lymphocytes, and mature dendritic cells (PMID: 28861320). It exerts both activating and inhibitory effects depending on the expression status of SAP or EAT-2. SLAMF7 is overexpressed in multiple myeloma and makes it a target for immunotherapy (PMID: 28861320).

{{ptg:RelatedPrimaryAntibodies}}